Trial Profile
Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2019
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics; Therapeutic Use
- 20 Mar 2019 Status changed from recruiting to completed.
- 20 Nov 2005 New trial record.